AQST Q2 2019 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$427M

Q2 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$11M-20.1% YoY

Gross Profit

$6M51.3% margin

Operating Income

-$19M-167.9% margin

Net Income

-$20M-184.0% margin

EPS (Diluted)

$-0.82

QoQ Revenue Growth

-12.0%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$50M

Total Liabilities

$75M

Stockholders' Equity

-$25M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$14M	-20.1%
Gross Profit	$6M	$9M	-36.2%
Operating Income	-$19M	-$33M	+42.8%
Net Income	-$20M	-$36M	+43.9%

Revenue Segments

Manufacture and Supply Revenue

$9M95%

License and Royalty Revenue

$424,0005%